Pathobiologic Findings in DCIS of the Breast: Morphologic Features, Angiogenesis, HER-2/neu and Hormone Receptors
Authors:
- Michael P. DiGiovannaMDMichael P. DiGiovanna
- 1 June 2001
- journal article
- Published by Elsevier in Experimental and Molecular Pathology
- Vol. 70 (3) , 303-316
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Ductal Carcinoma In Situ of the Breast: Frequency of Biomarkers According to Histologic SubtypeApplied Immunohistochemistry & Molecular Morphology, 1999
- Prediction of local recurrence of ductal carcinoma in situ of the breast using five histological classifications: A comparative study with long follow-upHuman Pathology, 1998
- Ductal carcinoma in situ: Assessment of necrosis and nuclear morphology and their association with biological markersThe Journal of Pathology, 1995
- Tumor Angiogenesis as a Prognostic Assay for Invasive Ductal Breast CarcinomaJNCI: Journal of the National Cancer Institute, 1995
- Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancerHuman Pathology, 1992
- HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma.Journal of Clinical Oncology, 1992
- Association of c-erbB-2 expression and S-phase fraction in the prognosis of node positive breast cancerAnnals of Oncology, 1991
- Results of treating ductal carcinomaIn situ of the breast with conservative surgery and radiation therapyCancer, 1991
- Potential Value of Hormone Receptor Assay in Carcinoma In Situ of BreastAmerican Journal of Clinical Pathology, 1990
- Recurrence after lumpectomy for comedo-type intraductal carcinoma of the breastThe American Journal of Surgery, 1990